Merrimack Pharmaceuticals
MACK
$14.98
Share price
1.63%
Change (1 day)
18.98%
Change (1 year)
Categories
Merrimack Pharmaceuticals (MACK) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.44 M
According to Merrimack Pharmaceuticals's latest financial reports the company's total liabilities are $0.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Merrimack Pharmaceuticals - Total liabilities on balance sheet (from 2010 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.44 M | -25.13% |
| 2022-12-31 | $0.58 M | 4.8% |
| 2021-12-31 | $0.56 M | -27.01% |
| 2020-12-31 | $0.77 M | -72.2% |
| 2019-12-31 | $2.77 M | -90.68% |
| 2018-12-31 | $29.72 M | 41.26% |
| 2017-12-31 | $21.04 M | -93.7% |
| 2016-12-31 | $0.33 B | -20.17% |
| 2015-12-31 | $0.41 B | 60.63% |
| 2014-12-31 | $0.26 B | 10.63% |
| 2013-12-31 | $0.23 B | 51.58% |
| 2012-12-31 | $0.15 B | 45.24% |
| 2011-12-31 | $0.10 B | -61.31% |
| 2010-12-31 | $0.27 B | 1.32% |
| 2009-12-31 | $0.27 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $57.61 B | 13,064,072.34% | 🇫🇷 France |
 Geron GERN | $0.14 B | 33,035.37% | 🇺🇸 USA |
 Clovis Oncology CLVS | $0.76 B | 173,292.52% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $72.38 M | 16,314.51% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $46.89 M | 10,534.69% | 🇺🇸 USA |